Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma (MM)

Explore clinical trials studying Multiple Myeloma (MM). Study availability and eligibility vary by location and protocol.

56 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma (MM) trial results

Recruiting

Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution

NCT07214324

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations
  • Istituto Ortopedico Rizzoli IRCCS Bologna, Italy
  • UO Ematologia Azienda Ospedaliero-Universitaria "Policlinico Rodolico San Marco" Catania, Italy
  • UOC di Ematologia, Dipartimento di Oncologia, AOU Policlinico "Paolo Giaccone" Palermo, Italy
  • S.C Ematologia - Azienda USL IRCCS di Reggio Emilia Reggio Emilia, Italy
View Trial Details
Recruiting

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

NCT07107529

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • IT-Ascoli Piceno-Ospedale Mazzoni [01-016] Ascoli Piceno, Italy
  • IT-Bari-A.O.U. Consorziale Policlinico - Medicina Interna [01-018] Bari, Italy
  • IT-Bergamo-A.O. Papa Giovanni XXIII [01-003] Bergamo, Italy
  • IT-Bologna-A.O.U. di Bologna - Policlinico S. Orsola Malpighi [01-004] Bologna, Italy
View all 29 locations
View Trial Details
Recruiting

A Phase 1/2 Study of IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT05908409

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
Locations
  • Hospital Universitario Marques de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario de Salamanca Salamanca, Castille and León, Spain
  • Hospital Universitari Vall d'hebron Barcelona, Spain
  • Hospital Durán i Reynals - ICO L´Hospitalet Barcelona, Spain
View Trial Details
Recruiting

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

NCT06821880

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia (CLL), +20 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Tyrolia, Austria
  • Medizinische Universität Graz Graz, Austria
  • BKH Kufstein Kufstein, Austria
  • Onkologischer Schwerpunkt am Oskar-Helene-Heim Berlin, Germany
View Trial Details
Recruiting

A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence

NCT06767254

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS Meldola, Forlì-Cesena, Italy
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
  • ARNAS "G. Brotzu" di Cagliari Cagliari, Italy
  • Azienda Ospedaliera Universitaria Federico II Naples, Italy
View Trial Details

Related conditions